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In view of the emerging importance of ionic liquids as reaction media in organic 
synthesis, researchers have recently focused on the synthesis of chiral ionic liquids 
(CILs) for their particularly potential applications to chiral discrimination. The study 
of the application of CILs in asymmetric synthesis is not only an opportunity but 
also a challenge for researchers. Herein, the synthesis of new CILs based on alkyl-
imidazole as the cation and four different chiral acids as the anion were reported. 
 
Eighteen chiral ionic liquids were synthesized and characterized by a variety of 
physico-chemical techniques. Four different chiral acids chosen were L-lactic acid, 
L-tartaric acid, (R)-(-)-camphor-10-sulfonic acid and L-malic acid. Imidazole was 
chosen because they are easier to prepare and less toxic compared to thiazole and 
pyrrolidine which contain sulfur and nitrogen compounds respectively. These salts 
were prepared using simple ion-exchange reaction which gave good overall yield (> 
95 %) at room temperature. All the CILs synthesized are hygroscopic. Their 
enantiomeric purity was analyzed using 1H NMR spectroscopy. The effect of alkyl 
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substituents bonded to the nitrogen on imidazolium cation on the physical properties 
especially its melting point was also examined and observed. The melting points for 
bulkier ionic liquids are higher as compared to those of small ionic liquids. For the 
solid CILs, their solubility in organic solvents were tested and followed by 
recrystallization. Their three dimensional network of cation-anion and hydrogen 
bonding were analyzed by single-crystal X-ray diffraction analysis. Each CILs 
optical polarity was measured using polarimeter.  
 
An example of the application of CILs is in biocatalysis. Chiral ionic liquid coated-
enzyme (CILCE) was prepared by coating Candida rugosa lipase with 1-hydrogen-
3-hexylimidazolium hydrogen-tartrate. CILCE was then used to catalyze some non-
chiral and chiral esterification reactions. For non-chiral esterification, we found that 
CILCE gave higher percentage of conversion compared to native enzyme for short 
and medium chain acids, where all acids were reacted with oleyl alcohol. For chiral 
esterification, enantioselective esterification of (±)-menthol with butyric anhydride 
was studied. Percentage conversion of menthyl butyrate in CILCE (81.91 %) was 
better than in CRL (28.19 %). However, its enantiomeric excess (ee) from CILCE 
was low compared to CRL with 1.1 and 3.3, respectively calculated from its 
enantiomeric value, E.  
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Fakulti: Sains 
 
Dewasa ini, kepentingan cecair ionik sebagai media tindak balas dalam sintesis 
organik semakin berkembang. Kini, para penyelidik mula memfokuskan kepada 
sintesis cecair ionik kiral (CILs) yang berpotensi dalam aplikasi diskriminasi kiral. 
Kajian aplikasi CILs dalam sintesis asimetri bukan hanyalah satu peluang malah 
juga adalah satu cabaran bagi para penyelidik. Dalam kajian ini, sintesis CILs baru 
yang berasaskan alkil-imidazol sebagai kation dan pelbagai asid kiral sebagai anion 
dilaporkan. 
 
Lapan belas CILs telah disintesis dan dicirikan menggunakan pelbagai teknik kimia-
fizikal. Empat asid kiral berlainan yang dipilih adalah L-asid laktik, L-asid tartarik, 
(R)-(-)-asid camphor-10-sulfonik dan L-asid malik. Imidazol telah dipilih kerana ia 
mudah disediakan dan kurang toksik jika dibandingkan dengan thiazol dan 
piroldinium yang mengandungi sulfur dan nitrogen. Kesemua garam ini telah 
disediakan menggunakan kaedah tindak balas penukargantian-ion mudah yang 
memberikan hasil yang tinggi (> 95 %) pada suhu bilik. Kesemua cecair ionik kiral 
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yang disintesis adalah higroskopik. Ketulenan enantiomerik CILs dicirikan 
menggunakan 1H spektroskopi magnetik resonan nuklear (NMR). Kesan 
penukargantian alkil dalam ciri-ciri fizikal khususnya terhadap takat leburnya juga 
telah diuji dan diperhatikan. Takat lebur bagi cecair ionik yang lebih besar saiznya 
adalah lebih tinggi jika dibandingkan dengan cecair ionik yang lebih kecil.  Bagi 
cecair ionik pepejal, keterlarutan dalam pelarut organik diuji, diikuti oleh 
penghabluran semula. Rangkaian tiga dimensi antara kation-anion dan ikatan 
hidrogen dianalisis menggunakan X-ray serakan kristal tunggal. Polariti optik bagi 
setiap cecair ionik diukur dengan menggunakan polarimeter.  
 
Salah satu contoh aplikasi CILs adalah dalam biopemangkinan. Enzim bersalut 
cecair ionik kiral (CILCE) disediakan dengan menyalut lipase Candida rugosa 
dengan 1-hidrogen-3-heksilimidazolium hidrogen-tartrat. CILCE kemudiannya 
digunakan untuk memangkin beberapa tindak balas pengesteran mudah tak-kiral dan 
kiral. Bagi pengesteran tak-kiral, CILCE memberikan peratusan penukaran yang 
lebih tinggi berbanding enzim asli bagi asid berantai pendek dan sederhana, di mana 
semua asid ditindak balaskan dengan olil alkohol. Bagi pengesteran kiral, 
pengesteran enantioselektif bagi (±)-menthol dengan butirik anhidrida telah dikaji. 
Peratus penukaran menthil butirat dalam CILCE (81.41 %) adalah lebih bagus 
daripada dalam CRL (28.19 %). Walau bagaimanapun, lebihan enantiomerik, (ee) 
daripada CILCE adalah rendah berbanding CRL dan masing-masing memberikan 
1.1 dan 3.3 bagi nilai enantiomeriknya, E. 
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CHAPTER 1 
1. INTRODUCTION 
 
As we advanced into the 21st century, it has become more evident that chiral drugs 
have become a major focus of most pharmaceutical companies. The increasing 
demand for many organic esters and chiral drugs creates the need for developing 
highly specific catalyst and for this reason, the application of enzymes as the catalyst 
for the synthesis of esters is undergoing rapid development (Garcia et al., 1996; 
Gryglewicz, 2003).  Enzymatic synthesis offers various advantages over chemical 
synthesis such as lower energy requirement and enhanced selectivity and quality of 
the product.  Moreover, enzymes especially lipases have high specificity towards 
ester bond and hence eliminating the presence of undesirable side-reactions and by-
products in esterification reaction (Yadav and Devi, 2003). 
 
Chiral analysis is an important subject in science as well as in technology. 
Enantiomeric forms of many compounds are known to have different psychological 
and therapeutic effects. Very often, only one form of an enantiomeric pair is 
pharmacologically active. The other form of the same enantiomeric pair can reverse 
or otherwise limit the effect of the desired enantiomer. Recognizing the importance 
of chiral effects, the Food and Drug Administration (FDA) in 1992 issued a mandate 
requiring pharmaceutical companies to verify the enantiomeric purity of chiral drugs 
that are produced. It is, thus, hardly surprising that the pharmaceutical industry 
needs effective methods to determine enantiomeric purity and high enantiomeric 
excess (ee) (Tran et al., 2006).  
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Room temperature ionic liquids (ILs) are novel and promising materials for a variety 
of chemical applications. They have unique chemical and physical properties; 
including possessing a high solubility power and virtually no vapour pressure (Earle 
et al., 2000 and Earle and Seddon, 2000). Because of these two properties, they can 
serve as an alternative to the volatile organic compounds that are traditionally used 
as industrial solvents. In view of the emerging importance of ILs as reaction media 
in organic synthesis, researchers have focused on the synthesis of chiral ionic liquids 
(CILs) for their particularly potential applications to chiral discrimination, including 
asymmetric synthesis and optical resolution of racemates (Wang et al., 2005). Chiral 
ionic liquids therefore may offer a solution for determining enantiomeric purity and 
high ee in asymmetric reactions. 
 
The popularity stems from the fact that it is possible to use CILs to replace the 
organic solvent for the enantiomeric purity determination method. Specifically, the 
CILs with its high solubility power should dissolve many different types of analytes 
(Zhao and Malhotra, 2002). Its chirality may produce the needed diastereomeric 
interactions with both enantiomeric forms of an analyte. Unfortunately, despite their 
potentials, CILs have been synthesized and the synthesis of reported CILs required 
rather expensive reagents and elaborates synthetic schemes. Because of these 
limitations, the study and applications of CILs have been severely hindered (Tran et 
al., 2006). Therefore, it is of particular importance to develop a novel synthesis by 
which CILs can be simply and easily prepared from commercially available reagents 
by researchers. 
 
2 
 
